Stephen Mitchener, SVP, Chief Business Officer at Karyopharm Therapeutics Inc. (KPTI), sold 528 shares at $9.29 ($5K) on 2021-06-02, disclosed to the SEC on 2021-06-03.
Open-market sale of $5k KPTI by SVP, Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |